JP2016505039A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505039A5 JP2016505039A5 JP2015553775A JP2015553775A JP2016505039A5 JP 2016505039 A5 JP2016505039 A5 JP 2016505039A5 JP 2015553775 A JP2015553775 A JP 2015553775A JP 2015553775 A JP2015553775 A JP 2015553775A JP 2016505039 A5 JP2016505039 A5 JP 2016505039A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- metformin
- glp1r agonist
- glp1r
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361753567P | 2013-01-17 | 2013-01-17 | |
| US61/753,567 | 2013-01-17 | ||
| PCT/US2014/011394 WO2014113357A1 (en) | 2013-01-17 | 2014-01-14 | Combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505039A JP2016505039A (ja) | 2016-02-18 |
| JP2016505039A5 true JP2016505039A5 (cg-RX-API-DMAC7.html) | 2017-02-16 |
| JP6445459B2 JP6445459B2 (ja) | 2018-12-26 |
Family
ID=50030537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553775A Active JP6445459B2 (ja) | 2013-01-17 | 2014-01-14 | Ｇｌｐ１ｒアゴニストとメトホルミンの組合わせおよび２型糖尿病その他の障害の処置のためのその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150313908A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2945618B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6445459B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102165434B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104968341B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014207748B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2896308C (cg-RX-API-DMAC7.html) |
| EA (1) | EA201591123A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2687083T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL239714A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX366685B (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201704716XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014113357A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY207828A (en) | 2017-09-22 | 2025-03-21 | Regeneron Pharma | Glucagon-like peptide 1 receptor agonists and uses thereof |
| WO2019217165A1 (en) * | 2018-05-08 | 2019-11-14 | Vtv Therapeutics Llc | Therapeutic uses of glp1r agonists |
| JP2023528726A (ja) * | 2020-04-01 | 2023-07-06 | ハンジョウ ジョンメイ フアドン ファーマシューティカル シーオー．，エルティーディー． | Ｇｌｐ１ｒアゴニスト遊離塩基の薬学的に許容される酸塩類およびその調製法 |
| US12459954B2 (en) | 2020-04-01 | 2025-11-04 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Crystalline form a of GLP-1 receptor agonist and preparation method therefor |
| JP7728872B2 (ja) * | 2020-12-31 | 2025-08-25 | ドン・クク・ファーム・カンパニー・リミテッド | 新規な溶出率を示すタダラフィルまたはこの薬学的に許容される塩及びデュタステリドまたはこの薬学的に許容される塩を含む医薬組成物 |
| KR20250075642A (ko) | 2022-09-21 | 2025-05-28 | 리제너론 파아마슈티컬스, 인크. | 비만, 당뇨병 및 간 기능 장애를 치료하는 방법 |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4080472A (en) | 1974-03-22 | 1978-03-21 | Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. | Metformin 2-(p-chlorophenoxy)-2-methylpropionate |
| WO2007056387A2 (en) * | 2005-11-07 | 2007-05-18 | Elixir Pharmaceuticals, Inc. | Combinations of metformin and meglitinide |
| DK2262364T3 (en) * | 2008-03-07 | 2016-03-21 | Vtv Therapeutics Llc | Oxadiazoanthracenforbindelser for the treatment of diabetes |
| SG174205A1 (en) * | 2009-03-30 | 2011-10-28 | Transtech Pharma Inc | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| WO2011031620A1 (en) | 2009-09-11 | 2011-03-17 | Transtech Pharma, Inc. | Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| CA3011480C (en) * | 2009-11-13 | 2021-11-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine |
| US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| US20130040878A1 (en) * | 2011-05-13 | 2013-02-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
-
2014
- 2014-01-14 CN CN201480004613.0A patent/CN104968341B/zh active Active
- 2014-01-14 KR KR1020157018661A patent/KR102165434B1/ko active Active
- 2014-01-14 ES ES14702159.6T patent/ES2687083T3/es active Active
- 2014-01-14 WO PCT/US2014/011394 patent/WO2014113357A1/en not_active Ceased
- 2014-01-14 EP EP14702159.6A patent/EP2945618B1/en active Active
- 2014-01-14 CA CA2896308A patent/CA2896308C/en active Active
- 2014-01-14 SG SG10201704716XA patent/SG10201704716XA/en unknown
- 2014-01-14 JP JP2015553775A patent/JP6445459B2/ja active Active
- 2014-01-14 SG SG11201504778UA patent/SG11201504778UA/en unknown
- 2014-01-14 MX MX2015008555A patent/MX366685B/es active IP Right Grant
- 2014-01-14 AU AU2014207748A patent/AU2014207748B2/en active Active
- 2014-01-14 EA EA201591123A patent/EA201591123A1/ru unknown
-
2015
- 2015-06-30 IL IL239714A patent/IL239714A0/en unknown
- 2015-07-14 US US14/799,222 patent/US20150313908A1/en not_active Abandoned